宝济药业-B(02659)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02659 宝济药业-B

已收盘 01-12 16:08:28

79.600

+0.650

+0.82%

最高80.500	最低76.500	成交量9.03万
今开78.900	昨收78.950	日振幅5.07%
总市值259.48亿	流通市值122.58亿	总股本3.26亿
成交额710.53万	换手率0.06%	流通股本1.54亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"宝济药业-B","latestPrice":79.6,"timestamp":1768205308499,"preClose":78.95,"halted":0,"volume":90258,"delay":0,"floatShares":154000000,"shares":325981465,"eps":-7.619254672979316,"marketStatus":"已收盘","change":0.65,"latestTime":"01-12 16:08:28","open":78.9,"high":80.5,"low":76.5,"amount":7105324,"amplitude":0.050665,"askPrice":79.6,"askSize":500,"bidPrice":78.45,"bidSize":600,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":78.95,"openAndCloseTimeList":[[1768181400000,1768190400000],[1768194000000,1768204800000]],"volumeRatio":0.473592,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02659","defaultTab":"news","newsList":[{"id":"2601360951","title":"宝济药业-B01月08日主力净流入167.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601360951?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:16","pubTimestamp":1767860164,"startTime":"0","endTime":"0","summary":"01月08日, 宝济药业-B股价涨6.45%，报收80.10元，成交金额1058.4万元，换手率0.09%，振幅10.37%，量比0.40。宝济药业-B今日主力资金净流入167.4万元，上一交易日主力净流出62.7万元。该股近5个交易日上涨3.29%，主力资金累计净流出732.4万元；近20日主力资金累计净流入1503.2万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162946a4ab33a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108162946a4ab33a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02659"],"gpt_icon":0},{"id":"2601851223","title":"宝济药业-B(02659)全流通解读：资本优化如何赋能“场景驱动”战略？","url":"https://stock-news.laohu8.com/highlight/detail?id=2601851223","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601851223?lang=zh_cn&edition=full","pubTime":"2026-01-06 09:30","pubTimestamp":1767663013,"startTime":"0","endTime":"0","summary":"H股全流通不等于立即减持要准确评估宝济药业此次动作的影响，首先必须破除市场中普遍存在的认知误区，即将“全流通”视作“立即减持”的信号。对于宝济药业而言，全流通的价值更多体现在“资产可流动性”带来的心理溢价与融资弹性上。全流通背后的商业化考量与管线潜力宝济药业之所以在上市初期便推进全流通，其核心诉求在于通过提升股份流动性，实现股东利益与公司长期业绩的对齐，进而支撑其独特的“场景驱动”战略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02659","BK1161"],"gpt_icon":0},{"id":"2600370092","title":"宝济药业注射用BJ009启动生物利用度试验 适应症为细菌感染性疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2600370092","media":"新浪财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600370092?lang=zh_cn&edition=full","pubTime":"2025-12-31 12:31","pubTimestamp":1767155460,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，上海宝济药业股份有限公司的以注射用头孢唑林钠静脉输注作为对照，比较注射用BJ009制剂皮下输注在健康受试者中的药代动力学特征及绝对生物利用度的临床试验已启动。注射用BJ009为化学药物，适应症为敏感细菌所致的呼吸道、尿路、皮肤及软组织等感染。细菌感染性疾病由细菌入侵人体引起，症状因感染部位而异，常见发热、疼痛等，诊断依靠症状、血常规及细菌培养等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231123322a6e3f533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231123322a6e3f533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659","BK1161"],"gpt_icon":0},{"id":"2595798956","title":"宝济药业-B(02659)拟实施H股全流通计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2595798956","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595798956?lang=zh_cn&edition=full","pubTime":"2025-12-30 17:02","pubTimestamp":1767085361,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B(02659)发布公告，于2025年12月30日，公司已就拟实施H股全流通向中国证监会提交备案材料，以转换合共6311.63万股公司未上市股份为公司H股(占于本公告日期公司已发行股份总数约19.36%)。待取得所有相关批准(包括中国证监会的备案通知及联交所的批准)及符合所有适用法律、法规及规则后，该等未上市股份将转换为H股，且公司将申请批准该等H股于联交所主板上市及买卖。根据公司的公司章程，无须就批准转换及上市另行召开股东会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02659"],"gpt_icon":0},{"id":"2595299785","title":"安科生物：投资维升药业、宝济药业计入其他综合收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2595299785","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595299785?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:23","pubTimestamp":1767000200,"startTime":"0","endTime":"0","summary":"针对您提出的问题，结合公司年报披露的重要会计政策及会计估计，回复如下：一、关于投资的会计分类：公司以基石投资者身份投资维升药业、宝济药业港股的相关权益投资，不属于长期股权投资，公司在初始确认时将此类非交易性权益工具投资指定为以公允价值计量且其变动计入其他综合收益的金融资产。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251229/31899846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0060","02659","300009","BK1161","BK0070","BK0042","BK0239"],"gpt_icon":0},{"id":"2595482755","title":"宝济药业-B12月29日主力净流出366.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2595482755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595482755?lang=zh_cn&edition=full","pubTime":"2025-12-29 16:15","pubTimestamp":1766996107,"startTime":"0","endTime":"0","summary":"12月29日, 宝济药业-B股价跌2.87%，报收76.20元，成交金额3771.1万元，换手率0.32%，振幅4.21%，量比0.84。宝济药业-B今日主力资金净流出366.5万元，上一交易日主力净流入119.9万元。该股近5个交易日上涨4.83%，主力资金累计净流入763.1万元；近20日主力资金累计净流入1805.3万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161523a6dc32a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251229161523a6dc32a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02659"],"gpt_icon":0},{"id":"2594252202","title":"药闻 | 以定力穿越周期：从宝济样本看创新药企差异化突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2594252202","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594252202?lang=zh_cn&edition=full","pubTime":"2025-12-26 08:19","pubTimestamp":1766708355,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/KHMKOJ3C05568W0A.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/KHMKOJ3C05568W0A.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["02659"],"gpt_icon":0},{"id":"2594287555","title":"宝济药业-B12月24日获主力加仓156.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287555","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287555?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564143,"startTime":"0","endTime":"0","summary":"12月24日, 宝济药业-B股价涨5.59%，报收78.45元，成交金额2628.1万元，换手率0.22%，振幅5.38%，量比0.60。宝济药业-B今日主力资金净流入156.1万元，连续7日净流入，上一交易日主力净流入119.9万元。该股近5个交易日上涨8.66%，主力资金累计净流入1285.7万元；近20日主力资金累计净流入2327.9万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161938a4726e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161938a4726e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2593942679","title":"冰与火之歌：宝济药业(02589)180%暴涨vs华芢生物(02396)、翰思艾泰(03378)腰斩 港股生物科技新股极端分化启示录","url":"https://stock-news.laohu8.com/highlight/detail?id=2593942679","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593942679?lang=zh_cn&edition=full","pubTime":"2025-12-24 12:47","pubTimestamp":1766551655,"startTime":"0","endTime":"0","summary":"2025年12月，港股IPO市场上演了一场令人瞠目结舌的“冰与火之歌”。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20251224/20251224125033_33927.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251224/20251224125033_33927.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385346.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1535","BK1616","BK1173","03378","02659","02589","02396","159837","BK1233","BK1587"],"gpt_icon":1},{"id":"2593178488","title":"宝济药业-B12月22日获主力加仓177.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593178488","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593178488?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391339,"startTime":"0","endTime":"0","summary":"12月22日, 宝济药业-B股价涨1.71%，报收74.25元，成交金额3207.0万元，换手率0.28%，振幅2.95%，量比0.65。宝济药业-B今日主力资金净流入177.7万元，连续5日净流入，上一交易日主力净流入147.1万元。该股近5个交易日上涨12.66%，主力资金累计净流入1488.2万元；近20日主力资金累计净流入2051.9万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161844a6c087ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161844a6c087ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2592154232","title":"宝济药业-B12月19日获主力加仓147.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592154232","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592154232?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132151,"startTime":"0","endTime":"0","summary":"12月19日, 宝济药业-B股价涨0.69%，报收73.00元，成交金额4093.4万元，换手率0.36%，振幅4.41%，量比0.77。宝济药业-B今日主力资金净流入147.1万元，连续4日净流入，上一交易日主力净流入685.0万元。该股近5个交易日上涨6.80%，主力资金累计净流入1295.0万元；近20日主力资金累计净流入1874.3万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162059a45f244e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162059a45f244e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2591026826","title":"宝济药业-B12月16日主力净流入155.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2591026826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591026826?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:16","pubTimestamp":1765872960,"startTime":"0","endTime":"0","summary":"12月16日, 宝济药业-B股价涨1.59%，报收67.00元，成交金额3705.1万元，换手率0.36%，振幅5.16%，量比0.00。宝济药业-B今日主力资金净流入155.4万元，上一交易日主力净流出15.6万元。该股近5个交易日上涨153.98%，主力资金累计净流入719.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入719.1万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162249a4519163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216162249a4519163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":1},{"id":"2591616778","title":"宝济药业-B12月15日主力净流出15.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2591616778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591616778?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:15","pubTimestamp":1765786536,"startTime":"0","endTime":"0","summary":"12月15日, 宝济药业-B股价跌3.51%，报收65.95元，成交金额5059.6万元，换手率0.50%，振幅6.14%，量比0.00。宝济药业-B今日主力资金净流出15.6万元，上一交易日主力净流入13.1万元。该股近5个交易日上涨148.67%，主力资金累计净流入563.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入563.7万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161815a44d2d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215161815a44d2d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2590519099","title":"交银国际作为联席全球协调人助力宝济药业完成港股IPO项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2590519099","media":"交银国际","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590519099?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:41","pubTimestamp":1765460485,"startTime":"0","endTime":"0","summary":"宝济药业本次全球发售定价每股26.38港元，发行37,911,700股H股，融资规模约为10.00亿港元。交银国际担任联席全球协调人、联席账簿管理人兼联席牵头经办人，全程高效助力宝济药业顺利登陆港股资本市场。宝济药业已布局多个治疗领域的自主管线，拥有12款自主开发的在研和上市产品。通过将稳健的生产体系与前瞻性的研发能力深度融合，宝济药业已形成“创新研发—生物制造—临床转化”一体化的全产业链布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211214729a699b2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211214729a699b2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659","03329","BK1147"],"gpt_icon":1},{"id":"2590659546","title":"宝济药业-B12月11日主力净流入566.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590659546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590659546?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440949,"startTime":"0","endTime":"0","summary":"12月11日, 宝济药业-B股价涨9.52%，报收69.00元，成交金额1.4亿元，换手率1.43%，振幅13.10%，量比0.00。该股近5个交易日上涨165.35%，主力资金累计净流入566.1万元；近20日主力资金累计净流入566.1万元，其中净流入天数为1日。该股主力净额占比0.05%，港股市场排名89/2692。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162037a441f3a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162037a441f3a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02659"],"gpt_icon":0},{"id":"2590557916","title":"“自我造血”的新晋18A，宝济药业-B(02659)以“三驾马车”打造可持续增长样本","url":"https://stock-news.laohu8.com/highlight/detail?id=2590557916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590557916?lang=zh_cn&edition=full","pubTime":"2025-12-11 09:08","pubTimestamp":1765415296,"startTime":"0","endTime":"0","summary":"在这一背景下，宝济药业-B凭借与众不同的三驾“马车”，开辟了一条独特的差异化赛道，为行业提供了一种全新的Biotech生存逻辑与创新范式。这种由技术升级带来的高质量和高安全性，正是宝济药业在市场上实现“技术替代”红利的核心保障。目前，宝济药业已建成和在建的生产基地总占地面积近10万平方米，预计反应器总容积将达到约26,100L，年产能预计可达2250万份制剂。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380193.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02659"],"gpt_icon":1},{"id":"2590393379","title":"宝济药业-B(02659)捐款100万港元驰援香港大埔火灾 全力支持救灾重建工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393379","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590393379?lang=zh_cn&edition=full","pubTime":"2025-12-10 09:46","pubTimestamp":1765331195,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月26日，香港大埔宏福苑多栋住宅楼发生火灾，造成重大人员伤亡，灾情牵动着社会各界的心。值此艰难时刻，为帮助受灾同胞渡过难关，宝济药业-B(02659)积极履行企业社会责任，宣布捐款100万港元，用于受灾居民的紧急救援、生活物资补给、医疗救助及后续重建工作。宝济药业向遇难者及其家属表示沉痛哀悼，并向所有奋不顾身投入救援的消防及救护人员，以及第一时间响应的前线团队致以崇高敬意，感谢他们在危难关头展现的专业精神与无私付出。宝济药业将继续密切关注救灾进展，期盼在社会各界同心同力的援助下，社区早日恢复秩序，市民重归平安生活。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02659"],"gpt_icon":0},{"id":"1175227784","title":"异动解读 | 新股宝济药业-B(02659)首日盘中飙涨120.81%，公开发售超购3526倍引爆市场热情","url":"https://stock-news.laohu8.com/highlight/detail?id=1175227784","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175227784?lang=zh_cn&edition=full","pubTime":"2025-12-10 09:33","pubTimestamp":1765330391,"startTime":"0","endTime":"0","summary":"宝济药业-B今日盘中大涨120.81%，创下港股新股首日交易的亮眼表现。消息面上，宝济药业-B此次IPO获得市场狂热追捧，香港公开发售部分超额认购达3526.34倍，国际配售部分也获6.59倍认购。宝济药业是一家临床及商业化阶段的生物技术公司，专注于合成生物技术开发重组生物药物。公司2025年上半年收入同比大增2716%，展现出强劲的商业化潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02659"],"gpt_icon":0},{"id":"1167510070","title":"上海宝济药业-B在香港首日以每股60.5港元开盘，较发行价每股26.38港元大幅上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1167510070","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167510070?lang=zh_cn&edition=full","pubTime":"2025-12-10 09:22","pubTimestamp":1765329779,"startTime":"0","endTime":"0","summary":"上海宝济药业-B在香港首日的开盘价定为每股60.5港元，相较于发行价每股26.38港元大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":0},{"id":"1170105562","title":"港股开盘 | 恒指平开，科指低开0.04%！宝济药业-B首挂飙涨近130%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170105562","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170105562?lang=zh_cn&edition=full","pubTime":"2025-12-10 09:20","pubTimestamp":1765329630,"startTime":"0","endTime":"0","summary":"12月10日，恒生指数开盘上涨1.26点，涨幅0.0%，报25435.49点；恒生科技指数开盘下跌2.33点，跌幅0.04%，报5552.35点；国企指数开盘上涨0.46点，涨幅0.01%，报8936.87点；红筹指数开盘上涨14.33点，涨幅0.35%，报4144.82点。贵金属板块普涨，中国白银集团涨超7%，赤峰黄金涨近2%，招金矿业、、山东黄金、紫金黄金国际涨超1%；长飞光纤光缆跌超3%，拟折让约14.93%配售合共7000万股配售股份，净筹约22.29亿港元；宝济药业-B首挂飙涨近130%，此前公开发售获得3526.34倍认购，一手中签率7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","HSI","02659"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.baopharma.com","stockEarnings":[{"period":"1week","weight":0.1327},{"period":"1month","weight":0.2532},{"period":"ytd","weight":0.0181}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海宝济药业股份有限公司专注于重组蛋白药物和抗体药物的产业化与商业化。我们在上海建设了符合cGMP标准的生产基地，占地约63,000平方米，规划了多条覆盖哺乳动物细胞表达系统及大肠杆菌/酵母表达系统的原液生产线，以及水针剂、冻干粉针剂和一次性预灌封制剂的成品生产线。","exchange":"SEHK","name":"宝济药业-B","nameEN":"BAO PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宝济药业-B(02659)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宝济药业-B(02659)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宝济药业-B,02659,宝济药业-B股票,宝济药业-B股票老虎,宝济药业-B股票老虎国际,宝济药业-B行情,宝济药业-B股票行情,宝济药业-B股价,宝济药业-B股市,宝济药业-B股票价格,宝济药业-B股票交易,宝济药业-B股票购买,宝济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宝济药业-B(02659)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宝济药业-B(02659)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}